Successful Surgical Pulmonary Embolectomy for Massive Pulmonary Embolism with Multiple Thrombogenic Risk Factors: A Case Report
Yıl 2018,
Cilt: 21 Sayı: 1, 72 - 74, 01.04.2018
Hakan Fotbolcu
,
Erhan Kaya
Yeşim Demirel Barut
Ömer Işık
Cevat Yakut
Öz
We
report a 36-year old woman who suffered from massive pulmonary embolism with
multiple thrombogenic risk factors. She was successfully treated with pulmonary
embolectomy. Our report reinforces the importance of early diagnosis in the
presence of a high clinical suspicion for pulmonary embolism. Furthermore,
surgical pulmonary embolectomy remains one of the most effective treatment
methods.
Kaynakça
- 1. Walther A, Böttiger BW. Pulmonary embolism. Wien Med Wochenschr 2008;158:610-4.
- 2. Horlander KT, Mannino DM, Leeper KV. Pulmonary embolism mortality in the United States, 19791998: an analysis using multiplecause mortality data. Arch Intern Med 2003;163:1711-7.
- 3. Goldhaber SZ. Pulmonary embolism. Lancet 2004;363:1295-305.
- 4. Kline JA, Hernandez Nino J, Jones AE, Rose GA, Norton HJ, Camargo CA Jr. Prospective study of the clinical features and outcomes of emergency department patients with delayed diagnosis of pulmonary embolism. Acad Emerg Med 2007;14:592-8.
- 5. Mullins MD, Becker DM, Hagspiel KD, Philbrick JT. The role of spiral volumetric computed tomography in the diagnosis of pulmonary embolism. Arch Intern Med 2000;160:293-8.
- 6. Perrier A, Howarth N, Didier D, Loubeyre P, Unger PF, de Moerloose P, et al. Performance of helical computed tomography in unselected outpatients with suspected pulmonary embolism. Ann Intern Med 2001;135:88-97.
- 7. Kujovich JL. Factor V Leiden thrombophilia. Genet Med 2011;13:1-16.
- 8. Yusuf M, Gupta A, Kumar A, Afreen S. Mechanism and pathophysiology of activated protein C-related factor V leiden in venous thrombosis. Asian J Transfus Sci 2012;6:47-8.
- 9. Ornstein DL, Cushman M. Cardiology patient page. Factor V Leiden. Circulation 2003;107:e94-7.
- 10. Lauque D, Mazières J, Rouzaud P, Sié P, Chamontin B, Carrié D, et al. Pulmonary embolism in patients using estrogenprogestagen contraceptives. Presse Med 1998;27:15669.
- 11. Lehmann R, Suess C, Leus M, Luxembourg B, Miesbach W, Lindhoff-Last E, et al. Incidence, clinical characteristics and longterm prognosis of travelassociated pulmonary embolism. Eur Heart J 2009;30:23341.
- 12. Antman EM, Cohen M, Bernink PJ, McCabe CH, Horacek T, Papuchis G, et al. The TIMI risk score for unstable angina/nonST elevation MI: a method for prognostication and therapeutic decision making. JAMA 2000;284:83542.
- 13. Manzoli L, De Vito C, Marzuillo C, Boccia A, Villari P. Oral contraceptives and venous thromboembolism: a systematic review and metaanalysis. Drug Saf 2012;35:191205.
- 14. Wu O, Robertson L, Twaddle S, Lowe GD, Clark P, Greaves M, et al. Screening for thrombophilia in highrisk situations: systematic review and costeffectiveness analysis. The thrombosis: risk and economic assessment of thrombophilia screening (TREATS) study. Health Technol Assess 2006;10:10010.
- 15. Gruettner J, Viergutz T, Bolte M, Henzler T, Schoenberg SO, Sudarski S, et al. Importance of risk factors for the evaluation of patients with a suspected pulmonary embolism. Exp Ther Med 2015;9:2281-4.
- 16. Konstantinides SV, Torbicki A, Agnelli G, Danchin N, Fitzmaurice D, Galiè N, et al. 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J 2014;35:3033-69.
- 17. Leacche M, Unic D, Goldhaber SZ, Rawn JD, Aranki SF, Couper GS, et al. Modern surgical treatment of massive pulmonary embolism: results in 47 consecutive patients after rapid diagnosis and aggressive surgical approach. J Thorac Cardiovasc Surg 2005;129:1018-23.
- 18. Malekan R, Saunders PC, Yu CJ, BrownKA, Gass AL, Spielvogel D, et al. Peripheral extracorporeal membrane oxygenation: comprehensive therapy for highrisk massive pulmonary embolism. Ann Thorac Surg 2012;94:104-8.
- 19. Aklog L, Williams CS, Byrne JG, Goldhaber SZ. Acute pulmonary embolectomy: a contemporary approach. Circulation 2002;105:1416-9.
Çoklu Trombojenik Risk Faktörüne Sahip Masif Pulmoner Emboli Olgusunun Başarılı Bir Şekilde Cerrahi Pulmoner Embolektomi ile Tedavisi: Olgu Sunumu
Yıl 2018,
Cilt: 21 Sayı: 1, 72 - 74, 01.04.2018
Hakan Fotbolcu
,
Erhan Kaya
Yeşim Demirel Barut
Ömer Işık
Cevat Yakut
Öz
Otuz
altı yaşında, çoklu trombojenik risk faktörüne sahip ve masif pulmoner emboli
tablosu ile başvuran hastanın pulmoner embolektomi ile başarılı bir şekilde
tedavi edilişini sunuyoruz. Olgumuz pulmoner emboli de erken tanının önemini
belirtmektedir. Ayrıca, cerrahi pulmoner embolektominin en etkin tedavi
yöntemlerinden biri olduğunu vurgulamaktadır.
Kaynakça
- 1. Walther A, Böttiger BW. Pulmonary embolism. Wien Med Wochenschr 2008;158:610-4.
- 2. Horlander KT, Mannino DM, Leeper KV. Pulmonary embolism mortality in the United States, 19791998: an analysis using multiplecause mortality data. Arch Intern Med 2003;163:1711-7.
- 3. Goldhaber SZ. Pulmonary embolism. Lancet 2004;363:1295-305.
- 4. Kline JA, Hernandez Nino J, Jones AE, Rose GA, Norton HJ, Camargo CA Jr. Prospective study of the clinical features and outcomes of emergency department patients with delayed diagnosis of pulmonary embolism. Acad Emerg Med 2007;14:592-8.
- 5. Mullins MD, Becker DM, Hagspiel KD, Philbrick JT. The role of spiral volumetric computed tomography in the diagnosis of pulmonary embolism. Arch Intern Med 2000;160:293-8.
- 6. Perrier A, Howarth N, Didier D, Loubeyre P, Unger PF, de Moerloose P, et al. Performance of helical computed tomography in unselected outpatients with suspected pulmonary embolism. Ann Intern Med 2001;135:88-97.
- 7. Kujovich JL. Factor V Leiden thrombophilia. Genet Med 2011;13:1-16.
- 8. Yusuf M, Gupta A, Kumar A, Afreen S. Mechanism and pathophysiology of activated protein C-related factor V leiden in venous thrombosis. Asian J Transfus Sci 2012;6:47-8.
- 9. Ornstein DL, Cushman M. Cardiology patient page. Factor V Leiden. Circulation 2003;107:e94-7.
- 10. Lauque D, Mazières J, Rouzaud P, Sié P, Chamontin B, Carrié D, et al. Pulmonary embolism in patients using estrogenprogestagen contraceptives. Presse Med 1998;27:15669.
- 11. Lehmann R, Suess C, Leus M, Luxembourg B, Miesbach W, Lindhoff-Last E, et al. Incidence, clinical characteristics and longterm prognosis of travelassociated pulmonary embolism. Eur Heart J 2009;30:23341.
- 12. Antman EM, Cohen M, Bernink PJ, McCabe CH, Horacek T, Papuchis G, et al. The TIMI risk score for unstable angina/nonST elevation MI: a method for prognostication and therapeutic decision making. JAMA 2000;284:83542.
- 13. Manzoli L, De Vito C, Marzuillo C, Boccia A, Villari P. Oral contraceptives and venous thromboembolism: a systematic review and metaanalysis. Drug Saf 2012;35:191205.
- 14. Wu O, Robertson L, Twaddle S, Lowe GD, Clark P, Greaves M, et al. Screening for thrombophilia in highrisk situations: systematic review and costeffectiveness analysis. The thrombosis: risk and economic assessment of thrombophilia screening (TREATS) study. Health Technol Assess 2006;10:10010.
- 15. Gruettner J, Viergutz T, Bolte M, Henzler T, Schoenberg SO, Sudarski S, et al. Importance of risk factors for the evaluation of patients with a suspected pulmonary embolism. Exp Ther Med 2015;9:2281-4.
- 16. Konstantinides SV, Torbicki A, Agnelli G, Danchin N, Fitzmaurice D, Galiè N, et al. 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J 2014;35:3033-69.
- 17. Leacche M, Unic D, Goldhaber SZ, Rawn JD, Aranki SF, Couper GS, et al. Modern surgical treatment of massive pulmonary embolism: results in 47 consecutive patients after rapid diagnosis and aggressive surgical approach. J Thorac Cardiovasc Surg 2005;129:1018-23.
- 18. Malekan R, Saunders PC, Yu CJ, BrownKA, Gass AL, Spielvogel D, et al. Peripheral extracorporeal membrane oxygenation: comprehensive therapy for highrisk massive pulmonary embolism. Ann Thorac Surg 2012;94:104-8.
- 19. Aklog L, Williams CS, Byrne JG, Goldhaber SZ. Acute pulmonary embolectomy: a contemporary approach. Circulation 2002;105:1416-9.